Infliximab for ulcerative colitis.
James M
JM
Becker
Scott G
SG
Prushik
Arthur F
AF
Stucchi
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000628:therapy*; D039021:Colonic Pouches / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D019449:Pouchitis / Q000453:epidemiology* / Q000209:etiology; D017211:Treatment Failure; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab